Influence of γ-secretase inhibition by DAPT on frequency of cell subsets in FTOC seeded with human CD34+CD1- thymic progenitor cells after 13 and 19 days of culture
. | . | DAPT treatment . | . | |
---|---|---|---|---|
Cell subset . | Control . | 5 μM . | 10 μM . | |
After 13 days | ||||
CD4ISP | 57.3 ± 1.7 | 43.0 ± 2.6 | 35.3 ± 0.8 | |
DP | 14.7 ± 6.0 | 52.6 ± 5.4* | 56.7 ± 0.6* | |
IC TCR-β | 26.3 ± 7.1 | 1.3 ± 0.1* | 0.9 ± 0.2* | |
CD3+ | 17.9 ± 4.6 | 1.0 ± 0.2* | 0.8 ± 0.2* | |
TCR-αβ | 1.3 ± 0.3 | 0.5 ± 0.1* | 0.3 ± 0.1* | |
TCR-γδ | 4.0 ± 0.5 | 0.2 ± 0.1* | 0.1 ± 0.0* | |
After 19 days | ||||
CD56+ | 0.2 ± 0.1 | 2.7 ± 0.3* | 8.3 ± 2.1* | |
CD4ISP | 34.4 ± 6.3 | 16.6 ± 5.2* | 8.7 ± 2.0* | |
DP | 56.3 ± 9.3 | 68.9 ± 8.8* | 71.1 ± 3.6* | |
IC TCR-β | 63.4 ± 7.1 | 5.3 ± 1.2* | 2.1 ± 1.7* | |
CD3+ | 50.6 ± 3.5 | 5.1 ± 0.5* | 5.1 ± 0.8* | |
TCR-αβ | 36.8 ± 3.8 | 2.3 ± 0.6* | 2.3 ± 0.5* | |
TCR-γδ | 3.3 ± 0.9 | 0.4 ± 0.1* | 0.9 ± 0.5* |
. | . | DAPT treatment . | . | |
---|---|---|---|---|
Cell subset . | Control . | 5 μM . | 10 μM . | |
After 13 days | ||||
CD4ISP | 57.3 ± 1.7 | 43.0 ± 2.6 | 35.3 ± 0.8 | |
DP | 14.7 ± 6.0 | 52.6 ± 5.4* | 56.7 ± 0.6* | |
IC TCR-β | 26.3 ± 7.1 | 1.3 ± 0.1* | 0.9 ± 0.2* | |
CD3+ | 17.9 ± 4.6 | 1.0 ± 0.2* | 0.8 ± 0.2* | |
TCR-αβ | 1.3 ± 0.3 | 0.5 ± 0.1* | 0.3 ± 0.1* | |
TCR-γδ | 4.0 ± 0.5 | 0.2 ± 0.1* | 0.1 ± 0.0* | |
After 19 days | ||||
CD56+ | 0.2 ± 0.1 | 2.7 ± 0.3* | 8.3 ± 2.1* | |
CD4ISP | 34.4 ± 6.3 | 16.6 ± 5.2* | 8.7 ± 2.0* | |
DP | 56.3 ± 9.3 | 68.9 ± 8.8* | 71.1 ± 3.6* | |
IC TCR-β | 63.4 ± 7.1 | 5.3 ± 1.2* | 2.1 ± 1.7* | |
CD3+ | 50.6 ± 3.5 | 5.1 ± 0.5* | 5.1 ± 0.8* | |
TCR-αβ | 36.8 ± 3.8 | 2.3 ± 0.6* | 2.3 ± 0.5* | |
TCR-γδ | 3.3 ± 0.9 | 0.4 ± 0.1* | 0.9 ± 0.5* |
Results represent mean percentage ± SEM of 3 to 5 independent experiments.
Significant difference (P < .05; paired Student t test) compared with vehicle-treated control cultures